Health Care & Life Sciences » Pharmaceuticals | GRUPO International Inc.

GRUPO International Inc.

GRUPO International Inc.
Stock Exchange Other OTC
EPS
-
Market Cap
$644.46 K
Shares Outstanding
10.43 M
Public Float
5.54 M

Profile

Address
14 Laurel Boulevard
Collingwood Ontario L9Y 5A8
Canada
Employees -
Website -
Updated 07/08/2019
Grupo International, Inc. operates as a development stage company, which is engaged in development and marketing of a proposed vaccine designed to combat HIV/AIDS. The company operates through two distinct divisions: The Pharmaceutical Division and The Basic Materials Division. The Pharmaceutical division will continually look for medical cures.

Financials

View All

Kevin W. Murray
Chairman, President, CEO & CFO